Skip to content
Screener

EBITDA margin at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-66.3%-213pp
ALN
Alnylam PharmaceuticalsALNY
22%+18.5pp
Assembly Biosciences logo
Assembly BiosciencesASMB
-116.5%-26.0pp
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
81.8%+42.2pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-69%-6.4pp
Beam Therapeutics logo
Beam TherapeuticsBEAM
-212.9%-85.3pp

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

Based on trailing twelve months.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047

FAQ

What is Arrowhead Research's EBITDA margin?
Arrowhead Research (ARWR) reported EBITDA margin of -31.6% in Q1 2026.
How has Arrowhead Research's EBITDA margin changed year-over-year?
Arrowhead Research's EBITDA margin decreased by 76.8% year-over-year, from -17.9% to -31.6%.
What is the long-term trend for Arrowhead Research's EBITDA margin?
Over 4 years (2021 to 2025), Arrowhead Research's EBITDA margin has grown at a -38.3% compound annual growth rate (CAGR), from -101.8% to 14.7%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about Arrowhead Research's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude